Chronic myeloid leukemia (CML) is a blood cancer that starts in the bone marrow when a genetic change creates an overactive protein called BCR-ABL1. This “Philadelphia chromosome” fusion protein drives CML cells to grow out of control. The good news is that CML has been transformed by targeted drugs. Before 2001, CML was often deadly […]
